Alexion Pharmaceutical Inc. buy melinda
Start price
15.09.17
/
50%
€132.65
Target price
26.12.17
€175.89
Performance (%)
-18.99%
End price
26.12.17
€107.46
Summary
This prediction ended on 26.12.17 with a price of €107.46. The price of Alexion Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.99%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alexion Pharmaceutical Inc. | - | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
According to melinda what are the pros and cons of Alexion Pharmaceutical Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Alexion Pharmaceutical Inc. diskutieren
Pharma SecteurProduits
Alexion fügt Paul A. Friedman, MD in den Vorstand
- Der ehemalige Präsident und CEO von Incyte bringt umfangreiche Erfahrung in F & E und Biotechnologie -
(Vom Mitglied beendet)
Stopped prediction by melinda for Alexion Pharmaceutical Inc.
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€125.50
29.09.18
29.09.18
€130.79
12.03.20
12.03.20
-43.83%
12.03.20
12.03.20
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€112.84
09.03.18
09.03.18
€153.34
10.09.18
10.09.18
-6.26%
10.09.18
10.09.18
Could be worthwhile Investment >10% per year